Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Azenosertib (ZN-c3) in Patients With Ovarian CancerAdnexal Diseases, Carcinoma, Ovarian Epithelial, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, carcinoma, endocrine system disorder, epithelial neoplasm, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneum cancerRecruitingPhase 12026-04-07NCT04516447

1 results · Page 1 of 1

Swipe the table sideways for more columns.

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site 0103HoustonUnited States1
Site 0104BostonUnited States1
Site 0111St LouisUnited States1
Site 0173New YorkUnited States1
Site 0191ProvidenceUnited States1
Site 0196NashvilleUnited States1
Site 0259DurhamUnited States1
Site 0264AuroraUnited States1
Site 1001Banja LukaBosnia and Herzegovina1
Site 1002SarajevoBosnia and Herzegovina1
Site 1003TuzlaBosnia and Herzegovina1
Site 1201SofiaBulgaria1
Site 1202PanagyurishteBulgaria1
Site 1401TbilisiGeorgia1
Site 1902BelgradeSerbia1
Site 2705NedlandsAustralia1
Site 2706MelbourneAustralia1
Site 2707South BrisbaneAustralia1
Site 2708Sunshine CoastAustralia1
Site 2709AdelaideAustralia1
Site 2716MelbourneAustralia1
Site 2901BusanSouth Korea1
Site 2903SeoulSouth Korea1
Site 2904SeoulSouth Korea1